KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Payables (2016 - 2025)

Humana has reported Payables over the past 17 years, most recently at $6.0 billion for Q4 2025.

  • Quarterly results put Payables at $6.0 billion for Q4 2025, up 6.38% from a year ago — trailing twelve months through Dec 2025 was $6.0 billion (up 6.38% YoY), and the annual figure for FY2025 was $6.0 billion, up 6.38%.
  • Payables for Q4 2025 was $6.0 billion at Humana, up from $5.8 billion in the prior quarter.
  • Over the last five years, Payables for HUM hit a ceiling of $8.6 billion in Q2 2023 and a floor of $4.8 billion in Q4 2021.
  • Median Payables over the past 5 years was $6.1 billion (2022), compared with a mean of $6.3 billion.
  • Biggest five-year swings in Payables: dropped 20.83% in 2021 and later soared 38.8% in 2023.
  • Humana's Payables stood at $4.8 billion in 2021, then grew by 14.5% to $5.5 billion in 2022, then rose by 25.04% to $6.9 billion in 2023, then fell by 18.2% to $5.7 billion in 2024, then rose by 6.38% to $6.0 billion in 2025.
  • The last three reported values for Payables were $6.0 billion (Q4 2025), $5.8 billion (Q3 2025), and $5.9 billion (Q2 2025) per Business Quant data.